DVA · XBRL financial data

Davita financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (DVA's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Revenue	3,146*	3,071	3,187	3,264	3,295*	3,224	3,380	3,420	3,620*	3,416	3,554	3,578
General and administrative	401*	362	368	394	414*	374	413	414	472*	422	423	409
Operating income (loss)	390*	484	506	535	565*	439	538	506	561*	482	579	499
Interest expense	year only	—	—	—	year only	—	—	—	year only	—	—	—
Other income (expense)	(5)*	(13)	(27)	(17)	(13)*	(18)	(23)	(41)	(21)*	4	8	9
Income tax expense (benefit)	58*	66	72	78	64*	54	94	69	77*	66	92	89
Net income (loss)	151*	240	223	215	259*	163	199	150	234*	198	265	223
Earnings per share, basic USD per share	1.67*	2.73	2.56	2.56	3.18*	2.05	2.62	2.09	3.36*	2.93	4.10	3.49
Earnings per share, diluted USD per share	1.62*	2.65	2.50	2.50	3.09*	2.00	2.58	2.04	3.29*	2.87	4.02	3.40
Weighted average shares, basic millions of shares	90*	88	87	84	82*	79	76	72	70*	67	65	64
Weighted average shares, diluted millions of shares	93*	91	89	86	84*	81	77	74	71*	69	66	66

Balance sheet

CSV

Fiscal quarters (DVA's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Cash and cash equivalents	380	345	416	1,071	795	439	708	706	676	644	669	496
Marketable securities	12	11	21	21	51	73	31	31	24	22	20	71
Marketable securities, non-current	48	48	32	34	34	31	39	40	41	39	38	38
Accounts receivable	1,987	2,595	2,303	2,267	2,147	2,322	2,441	2,333	2,415	2,459	2,467	2,509
Inventory	143	146	127	129	135	151	146	139	161	142	152	161
Prepaid and other current assets	103	105	83	97	123	130	110	161	156	160	149	141
Total current assets	3,138	3,684	3,467	4,037	3,746	3,636	4,088	4,112	4,058	4,063	4,190	4,075
Property and equipment, net	3,074	3,026	2,982	2,940	2,941	2,901	2,854	2,853	2,813	2,755	2,749	2,731
Right-of-use asset	2,501	2,487	2,458	2,418	2,394	2,361	2,339	2,323	2,397	2,397	2,430	2,434
Goodwill	7,113	7,230	7,201	7,228	7,375	7,416	7,466	7,544	7,545	7,582	7,591	7,548
Total assets	16,894	17,431	17,026	17,504	17,285	17,119	17,493	17,556	17,480	17,499	17,709	17,817
Accounts payable	515	490	494	488	547	596	594	656	696	691	716	662
Total current liabilities	2,642	2,583	2,995	2,944	2,973	2,907	2,934	3,017	3,142	2,867	2,855	2,887
Lease liability, non-current	2,330	2,312	2,281	2,237	2,210	2,161	2,125	2,100	2,176	2,162	2,186	2,185
Total liabilities	14,150	14,795	14,601	15,284	15,194	15,459	15,940	16,215	16,322	16,451	16,630	16,691
Retained earnings (accumulated deficit)	598	838	1,061	1,275	1,535	1,698	1,897	2,047	(328)	(179)	81	302
Total stockholders' equity	1,056	926	633	387	121	(267)	(370)	(572)	(651)	(755)	(765)	(591)
Total liabilities and equity	16,894	17,431	17,026	17,504	17,285	17,119	17,493	17,556	17,480	17,499	17,709	17,817
Common shares outstanding (cover page) millions of shares	≈88	88	≈84	≈82	≈80	≈76	≈72	≈71	≈67	≈64	≈64	≈63

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Cash flows

CSV

Fiscal quarters (DVA's year ends in late December)

In millions of dollars	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026	Q3 FY26Sep 30, 2026
Net income (loss)	151*	240	223	215	259*	163	199	150	234*	198	265	223
Stock-based compensation	30*	25	24*	27*	27*	30	33*	39*	38*	28	26*	29*
Depreciation and amortization	year only	—	—	—	year only	—	—	—	year only	—	—	—
Net cash from operating activities	485*	(135)	799*	810*	548*	180	324*	842*	541*	321	490*	519*
Purchases of property and equipment	159*	121	125*	139*	171*	143	121*	166*	145*	102	170*	159*
Net cash from investing activities	(168)*	(215)	(162)*	(146)*	(248)*	(162)	(67)*	(263)*	(163)*	(139)	(194)*	(420)*
Share repurchases	272*	251	362*	408*	365*	510	284*	240*	274*	196	181*	73*
Dividends paid	year only	—	—	—	year only	—	—	—	year only	—	—	—
Proceeds from long-term debt	0*	1,290	1,985*	3,348*	1*	633	3,557*	482*	940*	1,263	1,505*	743*
Net cash from financing activities	(403)*	319	(563)*	(8)*	(565)*	(383)	4*	(582)*	(415)*	(213)	(270)*	(271)*
Net change in cash	(80)*	(34)	72*	655*	(279)*	(355)	272*	(2)*	(38)*	(31)	25*	(173)*

Compare with peers

SIC 8090 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (8090) companies nearest in public float, each marked “added: same SIC”.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Davita	496	3,578	519*	62.9M	Q3 FY26 10-QSep 30, 2026
Concentra Group Holdings Parent	158	606	135*	127.5M	Q2 FY26 10-QJun 30, 2026
Progynyadded: same SIC	153	351	50*	76.7M	Q2 FY26 10-QJun 30, 2026
Sotera Healthadded: same SIC	412	325	111*	285.6M	Q3 FY26 10-QSep 30, 2026
agilon healthadded: same SIC	174	1,519	50*	16.8M	Q3 FY26 10-QSep 30, 2026
Viemed Healthcareadded: same SIC	9.7	81	11*	37.9M	Q3 FY26 10-QSep 30, 2026
Park Dental Partnersadded: same SIC	24	66	4.7*	4.8M	Q2 FY26 10-QJun 30, 2026
Quipt Home Medicaladded: same SIC	11	81	8.9	44.5M	Q1 FY26 10-QDec 31, 2025
Cryo Cell Internationaladded: same SIC	1.4	7.8	1.1*	8.1M	Q3 FY26 10-QAug 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.